Aybala Erek

429 total citations
9 papers, 343 citations indexed

About

Aybala Erek is a scholar working on Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aybala Erek has authored 9 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aybala Erek's work include Inflammation biomarkers and pathways (2 papers), Restless Legs Syndrome Research (2 papers) and Big Data and Business Intelligence (1 paper). Aybala Erek is often cited by papers focused on Inflammation biomarkers and pathways (2 papers), Restless Legs Syndrome Research (2 papers) and Big Data and Business Intelligence (1 paper). Aybala Erek collaborates with scholars based in Türkiye, United States and Switzerland. Aybala Erek's co-authors include Tina D. Cunningham, Mitchell G. Scott, Robert E. Johnson, Osman Köstek, Mümtaz Takır, Barış Afşar, Ali Rıza Odabaş, Ömer Celal Elçioğlu, Richard J. Johnson and Mehmet Kanbay and has published in prestigious journals such as CHEST Journal, Clinical Chemistry and European Journal of Clinical Investigation.

In The Last Decade

Aybala Erek

9 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aybala Erek Türkiye 8 125 114 96 65 61 9 343
H Jakob Germany 11 174 1.4× 27 0.2× 37 0.4× 109 1.7× 20 0.3× 29 432
Ho Sik Shin South Korea 12 125 1.0× 108 0.9× 40 0.4× 53 0.8× 16 0.3× 47 397
Yue Xie China 10 21 0.2× 21 0.2× 37 0.4× 31 0.5× 9 0.1× 20 247
Per Ederoth Sweden 15 152 1.2× 35 0.3× 35 0.4× 82 1.3× 24 0.4× 30 516
Diego Tamariz United States 7 18 0.1× 22 0.2× 299 3.1× 29 0.4× 8 0.1× 7 433
Kwang‐No Lee South Korea 15 44 0.4× 15 0.1× 76 0.8× 57 0.9× 61 1.0× 53 759
Giovanna Romanato Italy 16 20 0.2× 118 1.0× 144 1.5× 130 2.0× 46 0.8× 25 514
Hammad Rahman United States 11 7 0.1× 89 0.8× 48 0.5× 146 2.2× 15 0.2× 21 389
Jürgen Berger Germany 8 12 0.1× 54 0.5× 161 1.7× 101 1.6× 2 0.0× 9 860
Virginia Garrote Argentina 10 6 0.0× 31 0.3× 27 0.3× 48 0.7× 13 0.2× 17 439

Countries citing papers authored by Aybala Erek

Since Specialization
Citations

This map shows the geographic impact of Aybala Erek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aybala Erek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aybala Erek more than expected).

Fields of papers citing papers by Aybala Erek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aybala Erek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aybala Erek. The network helps show where Aybala Erek may publish in the future.

Co-authorship network of co-authors of Aybala Erek

This figure shows the co-authorship network connecting the top 25 collaborators of Aybala Erek. A scholar is included among the top collaborators of Aybala Erek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aybala Erek. Aybala Erek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Erek, Aybala, et al.. (2020). Effects of hyperbilirubinemia on markers of genotoxicity and total oxidant and antioxidant status in newborns. Drug and Chemical Toxicology. 45(1). 451–455. 9 indexed citations
2.
Kanbay, Asiye, et al.. (2016). Endocan: A Novel Predictor of Endothelial Dysfunction in Obstructive Sleep Apnea Syndrome. CHEST Journal. 149(4). A588–A588. 7 indexed citations
3.
Takır, Mümtaz, Yalçın Solak, Aybala Erek, et al.. (2016). Association Between Elevated Serum Uric Acid and Vitamin D Insufficiency Among the Middle-Aged and Elderly Population. Turkish Nephrology Dialysis Transplantation. 25(2). 182–186. 7 indexed citations
4.
Kanbay, Asiye, Erkan Ceylan, Handan İnönü Köseoğlu, et al.. (2016). Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome. The Clinical Respiratory Journal. 12(1). 84–90. 32 indexed citations
5.
Takır, Mümtaz, Osman Köstek, Abdullah Özkök, et al.. (2015). Lowering Uric Acid with Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia. Journal of Investigative Medicine. 63(8). 924–929. 139 indexed citations
6.
Hurşitoğlu, Mehmet, et al.. (2011). Oxidative stress and autonomic nervous system functions in restless legs syndrome. European Journal of Clinical Investigation. 41(7). 734–742. 42 indexed citations
7.
Hurşitoğlu, Mehmet, Tufan Tükek, Rümeyza Kazancıoğlu, et al.. (2011). Urotensin II levels in patients with chronic kidney disease and kidney transplants. Upsala Journal of Medical Sciences. 117(1). 22–27. 7 indexed citations
8.
Hurşitoğlu, Mehmet, et al.. (2011). Prevalence of gluten sensitive enteropathy antibodies in restless legs syndrome.. PubMed. 111(4). 282–6. 10 indexed citations
9.
Erek, Aybala, et al.. (2010). Commutability Limitations Influence Quality Control Results with Different Reagent Lots. Clinical Chemistry. 57(1). 76–83. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026